Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Explore the best credit cards with rotating bonus categories to maximize your rewards. Find out how to earn more with smart choices.
26,498 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Baozun's baozun (bzun) 2025 earnings signal shifts in China’s DTC ecosystem. This article breaks down Q4 results, mar...
A clear read of SERA’s Q1 2026 numbers and management commentary can shift an investor’s view of 2026. This guide bre...
Investors are watching Cytek's 2026 earnings story unfold after Q1 results. This deep dive breaks down the key driver...
A rising wave of data centers and AI workloads is straining power grids. Learn how a strategic nuclear stock could ri...
A stunning earnings moment has sparked questions about AMD's role in AI infrastructure. This deep-dive breaks down wh...
As growth ETFs pivot in 2026, the case for a tighter mega-cap tilt strengthens. This analysis weighs performance, con...
Zero Network, a gasless Ethereum Layer 2 project, is closing its standalone chain after about 18 months of operation....
This deep dive breaks down NextPlat's Q1 2026 earnings, translating the numbers into practical takeaways for investor...
Regulators pause the Union Pacific Norfolk Southern megamerger review, injecting regulatory risk for Norfolk Southern...
A fresh cash-raising move and a strategic acquisition shook investors in Intuitive Machines. This article breaks down...
A 17% drop in NUGT on Friday highlights the peril of 2x leverage in mining ETFs as gold prices retreat and larger min...